Last update Feb. 14, 2022
Derivative of choline and cytidine involved in the biosynthesis of lecithin. Unproven properties of increasing cerebral blood flow and improving cognitive performance are attributed to it. It has been used in the treatment of cerebrovascular disorders such as stroke, parkinsonism and others. Intravenous, intramuscular or oral administration.
At the date of the last update we did not find any published data on its excretion in breast milk.
The paucity of known pharmacokinetic data does not allow prediction of its possible excretion in breast milk.
Safe product, free of toxicity, its side effects are rare and mild.
May decrease prolactin production. (Matsuoka 1978)
Its efficacy is not proven (Martí 2020, Dávalos 2012, Clark 1999) and it is considered a drug of low therapeutic utility, perfectly dispensable. (SEFAP 2012, DGF 2011, INSALUD 2001)
We do not have alternatives for Citicoline; Citicoline Sodium.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM